Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna Giovannini

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|January 10, 2026
Mapping ligands for MT<sub>1</sub>/MT<sub>2</sub> and 5-HT<sub>2C</sub> receptors: Chemotypes, SAR, and polypharmacologyAlban Lepailleur, Damien Geslin, Johanna Giovannini, et al.
ACS Chemical Neuroscience|September 26, 2022
On the Tracks of the Aggregation Mechanism of the PHF6 Peptide from Tau Protein: Molecular Dynamics, Energy, and Interaction Network InvestigationsCharline Fagnen, Johanna Giovannini, Marco Catto, et al.
Drug Discovery Today|January 27, 2022
Tau protein aggregation: Key features to improve drug discovery screeningJohanna Giovannini, Willy Smeralda, Marie Jouanne, et al.
European Journal of Medicinal Chemistry|July 15, 2023
Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studiesMahfam Moradi, Alireza Mousavi, Zahra Emamgholipour, et al.
ACS Chemical Neuroscience|October 15, 2024
Disruption of PHF6 Peptide Aggregation from Tau Protein: Mechanisms of Palmatine Chloride in Preventing Early PHF6 AggregationCharline Fagnen, Johanna Giovannini, Thomas Vignol, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Structure-Guided Discovery of a Nonpeptidic MT5-MMP InhibitorAntoine Magniez, Johanna Giovannini, Pauline Zipfel, et al.
Cancer Causes & Control : CCC|January 5, 2022
Reliability of baseline self-reported information in the AGRICAN cohortSéverine Tual, Clémentine Lemarchand, Johanna Giovannini, et al.
Journal of Cheminformatics|November 29, 2023
Towards a partial order graph for interactive pharmacophore exploration: extraction of pharmacophores activity deltaEtienne Lehembre, Johanna Giovannini, Damien Geslin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|January 10, 2026
Mapping ligands for MT<sub>1</sub>/MT<sub>2</sub> and 5-HT<sub>2C</sub> receptors: Chemotypes, SAR, and polypharmacologyAlban Lepailleur, Damien Geslin, Johanna Giovannini, et al.
ACS Chemical Neuroscience|September 26, 2022
On the Tracks of the Aggregation Mechanism of the PHF6 Peptide from Tau Protein: Molecular Dynamics, Energy, and Interaction Network InvestigationsCharline Fagnen, Johanna Giovannini, Marco Catto, et al.
Drug Discovery Today|January 27, 2022
Tau protein aggregation: Key features to improve drug discovery screeningJohanna Giovannini, Willy Smeralda, Marie Jouanne, et al.
European Journal of Medicinal Chemistry|July 15, 2023
Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studiesMahfam Moradi, Alireza Mousavi, Zahra Emamgholipour, et al.
ACS Chemical Neuroscience|October 15, 2024
Disruption of PHF6 Peptide Aggregation from Tau Protein: Mechanisms of Palmatine Chloride in Preventing Early PHF6 AggregationCharline Fagnen, Johanna Giovannini, Thomas Vignol, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Structure-Guided Discovery of a Nonpeptidic MT5-MMP InhibitorAntoine Magniez, Johanna Giovannini, Pauline Zipfel, et al.
Cancer Causes & Control : CCC|January 5, 2022
Reliability of baseline self-reported information in the AGRICAN cohortSéverine Tual, Clémentine Lemarchand, Johanna Giovannini, et al.
Journal of Cheminformatics|November 29, 2023
Towards a partial order graph for interactive pharmacophore exploration: extraction of pharmacophores activity deltaEtienne Lehembre, Johanna Giovannini, Damien Geslin, et al.
Pageof 1